|
Bridging the Health Gaps in Hereditary Angioedema: Demystifying Disparities, Enhancing Quality of Life, and Implementing Effective Prophylactic Solutions
Hereditary angioedema (HAE) is a rare, life-threatening disorder characterized by recurrent, unpredictable episodes of bradykinin-induced swelling. In this presentation, Dr. Marc Reidl, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center, reviews multiple underrecognized factors that contribute to health disparities among patients with HAE, including delays in diagnosis and multifaceted differences among racial and ethnic groups, socioeconomic status levels, ... |
|
The Pharmacist’s Role in Individualizing Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, immune-mediated neurologic disorder that can lead to severe disability if left untreated. Early and accurate diagnosis for CIDP is challenging and usually delayed, but early initiation and maintenance of immunoglobulin-based treatment is crucial. Due to the heterogenous nature of the disease, treatment strategies need to be individualized, and pharmacists play an integral role through ongoing patient communications/education, ... |